Ariya Bio (@ariyabioget) 's Twitter Profile
Ariya Bio

@ariyabioget

At Ariya Bio we focus on hereditary blood diseases and employ cutting-edge genome engineering tools to develop next-generation cell and gene therapies.

ID: 1690999678483980288

linkhttp://www.ariyabio.ch calendar_today14-08-2023 08:12:21

9 Tweet

26 Followers

34 Following

ETH Entrepreneurship (@eth_entprenship) 's Twitter Profile Photo
ETH Entrepreneurship
@eth_entprenship

5 years ago

Congratulations to our 7 new @ETHZurich Pioneer Fellows Paul Baade, Dominic Jud & Burak Cizmeci, Mandy Boontanrart, Karl-Philipp Schlichting, Sonia Meller & Hélène Iven with 5 thrilling projects. See what they do ethz.ch/pioneerfellows… Groundbreaking technology for the industry

Congratulations to our 7 new @ETHZurich Pioneer Fellows Paul Baade, Dominic Jud & Burak Cizmeci, Mandy Boontanrart, Karl-Philipp Schlichting, Sonia Meller & Hélène Iven with 5 thrilling projects. See what they do ethz.ch/pioneerfellows… Groundbreaking technology for the industry
NCCR RNA & Disease (@nccr_rnadisease) 's Twitter Profile Photo
NCCR RNA & Disease
@nccr_rnadisease

3 years ago

.ETH Foundation Spotlight "Hoping to heal" on ETH Pioneer Fellow Mandy Boontanrart and her company Ariya Bio. Her basic research in the Jacob Corn (D-BIOL @ ETH Zurich, ETH Zurich) was part of the Phase 2 project portfolio of the NCCR. bit.ly/3NIRjXF #haemoglobinopathies #CRISPR

.<a href="/ETHFoundation1/">ETH Foundation</a> Spotlight "Hoping to heal" on ETH Pioneer Fellow Mandy Boontanrart and her company Ariya Bio. Her basic research in the <a href="/jcornlab/">Jacob Corn</a> (<a href="/ETH_DBIOL/">D-BIOL @ ETH Zurich</a>, <a href="/ETH_en/">ETH Zurich</a>) was part of the Phase 2 project portfolio of the NCCR. bit.ly/3NIRjXF #haemoglobinopathies #CRISPR
Jacob Corn (@jcornlab) 's Twitter Profile Photo
Jacob Corn
@jcornlab

2 years ago

#CRISPR #globinopathy therapies target fetal globin. But delta globin is closer to adult globin *and* is expressed at low levels throughout life. ETH Entrepreneurship Fellow Mandy Boontanrart developed #geneediting "fix" for delta promoter! Finally out eLife - the journal elifesciences.org/articles/85258

ETH Zurich (@eth_en) 's Twitter Profile Photo
ETH Zurich
@eth_en

2 years ago

Anaemia is one of the most common hereditary diseases worldwide. ETH researcher Mandy Boontanrart has developed now a promising approach for its treatment. 🧬✂️ #CRISPRCas #GeneScissors #BloodPoverty Schweizerischer Nationalfonds (SNF) Innosuisse Learn more: 👇 fal.cn/3AogC

ETH Zürich (@eth) 's Twitter Profile Photo
ETH Zürich
@eth

2 years ago

Blutarmut gehört weltweit zu den häufigsten Erbkrankheiten. Die ETH-Forscherin Mandy Boontanrart hat nun einen vielversprechenden Ansatz für deren Behandlung entdeckt. 🧬✂️ #CRISPRCas #Genschere #Blutarmut Innosuisse Schweizerischer Nationalfonds (SNF) Erfahren Sie mehr:👇 fal.cn/3AogG

Jacob Corn (@jcornlab) 's Twitter Profile Photo
Jacob Corn
@jcornlab

2 years ago

I’m so excited to see Mandy Boontanrart and the Ariya Bio team push forward their new approach to tackle #globinopathy!

Kevin Davies (@kevinadavies) 's Twitter Profile Photo
Kevin Davies
@kevinadavies

2 years ago

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease -- my interview for Genetic Engineering & Biotechnology News with Mandy Boontanrart ETH Zurich on her clever strategy to switch up delta globin to treat #sicklecelldisease #CRISPR, just published eLife - the journal genengnews.com/topics/genome-…

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease -- my interview for <a href="/GENbio/">Genetic Engineering & Biotechnology News</a> with Mandy Boontanrart <a href="/ETH_en/">ETH Zurich</a> on her clever strategy to switch up delta globin to treat #sicklecelldisease #CRISPR, just published <a href="/eLife/">eLife - the journal</a> genengnews.com/topics/genome-…
Ariya Bio (@ariyabioget) 's Twitter Profile Photo
Ariya Bio
@ariyabioget

2 years ago

🙏 Big thanks to Kevin Davies and Genetic Engineering & Biotechnology News

The Nobel Prize (@nobelprize) 's Twitter Profile Photo
The Nobel Prize
@nobelprize

2 years ago

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.